Compass Therapeutics Net Tangible Assets

Compass Therapeutics (CMPX) currently reports a net tangible assets of $140M as of September 2026. That compares with $210M in the prior-year period — down 32.0% year over year. Use the charts on this page to explore Compass Therapeutics's net tangible assets history and peer comparisons.

Compass Therapeutics's net tangible assets decreased from $210M to $140M — a 32.0% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Compass Therapeutics reported $140M in net tangible assets as of September 2026. That compares with $210M in the prior-year period — down 32.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $140M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Compass Therapeutics, and consider following CMPX for alerts when major investors trade the stock.

Compass Therapeutics is classified in the Healthcare sector. On net tangible assets, it currently shows $140M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CMPX with unrelated industries.